I’m Shalini Mukherjee, PhD. As a BSI Clinical Evaluation Specialist and Scheme Manager for SaMD and active medical devices, I reviewed clinical evaluations on behalf of a Notified Body. Now I help medical device manufacturers write evaluations that hold up under that review.
Get in touchAuthoring and remediation of CEPs and CERs under EU MDR Annex XIV and current MDCG guidance, for initial certification, recertification and updates.
Summaries of Safety and Clinical Performance for implantable and Class III devices, written for both healthcare professionals and patients.
Post-market surveillance and PMCF plans and evaluation reports, and Periodic Safety Update Reports (PSURs) for Class III and implantable devices — all connected back to the CER’s conclusions and residual risks.
A specific specialty: structured, evidence-based responses to Notified Body questions and deficiencies during CER review rounds — written by someone who issued those questions at BSI. Includes pre-submission gap analysis so fewer questions land in the first place.
Clinical evaluation of software as a medical device in line with MDCG 2020-1, including clinical evidence strategy for AI-enabled devices.
Design and oversight of clinical investigations and PMCF studies — protocols, endpoints and data collection built to answer the exact questions your CER raises. I have designed and run clinical trials, and hold a master’s in Clinical Sciences.
Clinical and regulatory writing for US submissions, including 510(k) clinical sections — drawing on four FDA-cleared 510(k) programmes for surgical robotics.
Support across the whole device lifecycle — clinical evidence strategy before submission, the CER through certification, and lifecycle maintenance afterwards: CER updates, PMS/PMCF and PSUR cycles, and clinical assessment of device changes as your product evolves.
Class II/III devices: cardiovascular and vascular, cardiac rhythm management, PTA balloons, surgical and robotic systems, orthopaedics, SaMD and drug–device combinations.
Shalini Mukherjee, PhD, is a regulatory and clinical consultant with more than 20 years in scientific and medical writing and over 10 years in EU regulatory affairs for medical devices. From 2024 to 2026 she served at BSI as a Clinical Evaluation Specialist for active medical devices, and then as Clinical Evaluation Specialist and Scheme Manager for SaMD and active devices — assessing manufacturers’ clinical evidence from the Notified Body side.
She founded CER-Specialists in 2018 and has since consulted for large US and European device manufacturers. Clinical research is the other half of her practice: with an M.S. in Clinical Sciences (UT Southwestern), she has designed and managed clinical trials, including as a Clinical Project and Trial Manager in surgical robotics — where she also worked on four FDA-cleared 510(k) programmes — and in diagnostics. That trial-design experience now underpins her PMCF study work for MDR clients. She holds a PhD in Physiology (AIIMS, New Delhi), has completed MIT xPRO’s AI in Healthcare programme, and is an IAPP AIGP candidate.